A multiplex lateral flow immunoassay for simultaneous detection of SARS-CoV-2, influenza A, and influenza B. FDA-cleared for home-based testing with extended shelf-life stability.
Manufactured by
San Diego, CA, United States
ACON Laboratories is a privately owned medical device and diagnostics company headquartered in San Diego, California. Founded in 1996, the company specializes in manufacturing high-quality, affordable diagnostic and healthcare products, which are distributed in over 130 countries worldwide. Their product portfolio includes point-of-care diagnostics, diabetes care solutions, clinical chemistry products, immunoassays, and molecular diagnostics, serving hospitals, laboratories, physician offices, pharmacies, and veterinary clinics. ACON's facilities feature ISO 13485 certification and FDA registration, emphasizing their commitment to stringent quality standards and regulatory compliance. The company is recognized for ongoing innovation and development, aiming to improve health outcomes by providing accessible and reliable diagnostic products globally.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 7 relevant products
Xiamen Biotime Biotechnology Co., Ltd.
China · 1 relevant product
ZET MEDİKAL TEKSTİL DIŞ TİC.LTD.ŞTİ.
Türkiye · 3 relevant products
Wondfo USA Co., Ltd.
United States · 4 relevant products
Access Bio, Inc.
United States · 2 relevant products
Advin Biotech, Inc.
United States · 1 relevant product
CorDx
United States · 1 relevant product
Shenzhen Microprofit Biotech Co., Ltd
China · 1 relevant product
Boston Easy Biotech Inc.
United States · 2 relevant products
SureScreen Diagnostics Limited
United Kingdom · 4 relevant products
55 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 115 closest product alternatives
Jiangsu Medomics Medical Technology Co.,Ltd. · China
Multiplex lateral flow assay for simultaneous detection of COVID-19 and influenza A and B antigens. Allows differentiation of respiratory pathogens in a single test.
Xiamen Biotime Biotechnology Co., Ltd. · China
Multiplex rapid diagnostic test for simultaneous detection of SARS-CoV-2 antigen and influenza A/B viruses.
ZET MEDİKAL TEKSTİL DIŞ TİC.LTD.ŞTİ. · Türkiye
Multiplex lateral flow assay rapid test for simultaneous detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus antigens. Provides comprehensive respiratory pathogen screening.
Wondfo USA Co., Ltd. · United States
A combined rapid diagnostic test for simultaneous detection of COVID-19 and influenza A&B pathogens. FDA 510(k) cleared and Health Canada approved for home use.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
A lateral flow immunoassay combo test kit for rapid detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus (RSV) antigens. This multiplex test meets diverse respiratory pathogen detection needs.
Access Bio, Inc. · United States
Multiplexed rapid antigen home test detecting COVID-19, Influenza A, and Influenza B simultaneously. Single test for differentiation of common respiratory pathogens.
Advin Biotech, Inc. · United States
Multiplex rapid test simultaneously detecting COVID-19, influenza A, and influenza B from a single specimen. FDA cleared with results available in 5 minutes.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
A lateral flow immunoassay test kit for the simultaneous detection of SARS-CoV-2, Respiratory Syncytial Virus (RSV), Influenza A, and Influenza B antigens. This multiplex test identifies multiple respiratory pathogens in a single test.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
Rapid lateral flow immunoassay (LFIA) for simultaneous qualitative detection of SARS-CoV-2, influenza A and B, adenovirus, respiratory syncytial virus, and Streptococcus A antigens. Designed for point-of-care respiratory pathogen screening in clinical and self-testing settings.
CorDx · United States
Multiplex rapid immunoassay for simultaneous detection of Influenza A, Influenza B, and SARS-CoV-2 from respiratory specimens. Delivers results in approximately 15 minutes, enabling quick clinical decision-making in point-of-care and laboratory settings. Single-use test cartridge with integrated sample processing and built-in quality controls.
Shenzhen Microprofit Biotech Co., Ltd · China
CE-marked rapid self-test kit for simultaneous detection of SARS-CoV-2, Influenza A+B, and RSV with 92.9%+ sensitivity. Delivers point-of-care respiratory diagnostics using fluorescence immunoassay technology for clinical and home-based testing environments.
Boston Easy Biotech Inc. · United States
FDA-cleared rapid diagnostic test for simultaneous detection of Influenza A and B antigens. Provides fast, reliable results in clinical and point-of-care settings. Designed for ease of use and quick turnaround in respiratory infection screening.
103 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products